āĻšā§āĻŽCIPLA âĸ NSE
add
Cipla Ltd
ā§§,ā§Šā§§ā§Ģ.ā§§ā§Ļâš
ā§§ā§Š āĻŽāĻžāϰā§āĻ, ā§Š:ā§Ģ⧝:ā§Šā§Ģ PM GMT +ā§Ģ:ā§Šā§Ļ · INR · NSE · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āϏā§āĻāĻIN-āĻ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āϏāĻŋāĻāĻŋāĻāϰāĻŋāĻāĻŋIN-āĻ āĻšā§āĻĄāĻā§ā§āĻžāϰā§āĻāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§§,ā§Šā§¨ā§Ē.ā§Šā§Ļâš
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§§,ā§Šā§Ļā§§.ā§Ļā§Ļâš - ā§§,ā§Šā§¨ā§.ā§Ģā§Ļâš
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§§,ā§¨ā§Žā§§.ā§ā§Ļâš - ā§§,ā§Ŧā§ā§Š.ā§Ļā§Ļâš
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§§.ā§Ļā§Ŧ āϞāĻž.āĻā§. INR
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§§ā§Ģ.ā§Šā§ŽÂ āϞāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
ā§¨ā§Š.ā§Šā§Ž
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
ā§Ļ.⧝⧝%
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
NSE
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
| (INR) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§Ŧ.⧝ā§ŦāĻļāĻ¤Â āĻā§ | ā§Ļ.ā§Ļ⧍% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Š.ā§Šā§ĢāĻļāĻ¤Â āĻā§ | ⧧⧍.⧍ā§Ē% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Ŧā§ā§Ģ.ā§Žā§Ļ āĻā§ | -ā§Ģā§Ŧ.⧝ā§% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ⧝.ā§ā§§ | -ā§Ģā§Ŧ.⧝ā§Ŧ% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ā§§ā§Ļ.⧝ā§Ē | -ā§Ēā§Š.ā§ā§§% |
EBITDA | ā§§.⧍ā§ĻāĻļāĻ¤Â āĻā§ | -ā§Šā§.ā§Ēā§Ž% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ⧍ā§Ē.ā§Ēā§Ž% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (INR) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§§.ā§Ļā§ŦāĻā§ | ⧍⧧.ā§ā§Ģ% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | â | â |
āĻŽā§āĻ āĻĻāĻžā§ | â | â |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Š.ā§Šā§ĻāĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§Žā§Ļ.ā§ā§ŽÂ āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Š.⧍ā§Ģ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | â | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§.⧍⧝% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
| (INR) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Ŧā§ā§Ģ.ā§Žā§Ļ āĻā§ | -ā§Ģā§Ŧ.⧝ā§% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | â | â |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | â | â |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | â | â |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | â | â |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| â | â |
āϏāĻŽā§āĻĒāϰā§āĻā§
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
ā§§ā§¯ā§Šā§Ģ
āϏāĻĻāϰ āĻĻāĻĒā§āϤāϰ
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§Šā§Ļ,ā§Šā§§ā§Š